Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection-authors' reply
- PMID: 33333613
- DOI: 10.1111/apt.16162
Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection-authors' reply
Comment on
-
East Asia expert opinion on treatment initiation for chronic hepatitis B.Aliment Pharmacol Ther. 2020 Nov;52(10):1540-1550. doi: 10.1111/apt.16097. Epub 2020 Sep 20. Aliment Pharmacol Ther. 2020. PMID: 32951256 Review.
-
Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection.Aliment Pharmacol Ther. 2021 Jan;53(1):201-202. doi: 10.1111/apt.16132. Aliment Pharmacol Ther. 2021. PMID: 33333596 No abstract available.
References
REFERENCES
-
- Liu HT, Li ZC, Li C, et al. Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection. Aliment Pharmacol Ther. 2020;53:201-202.
-
- Kao J-H, Hu T-H, Jia J, et al. East Asia expert opinion on treatment initiation for chronic hepatitis B. Aliment Pharmacol Ther. 2020;52:1540-1550.
-
- Tseng T, Liu C, Yang H, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology. 2012;142:1140-1149.
-
- Tseng T-C, Liu C-J, Hsu C-Y, et al. High level of hepatitis B core-related antigen associated with increased risk of hepatocellular carcinoma in patients with chronic HBV infection of intermediate viral load. Gastroenterology. 2019;157:1518-1529.e3.
-
- Tada T, Kumada T, Toyoda H, et al. HBcrAg predicts hepatocellular carcinoma development: an analysis using time-dependent receiver operating characteristics. J Hepatol. 2016;65:48-56.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical